IPO Advicenne
06/12/2017
Listing of Advicenne on Euronext
Dr. Luc-André Granier, CEO and co-founder of Advicenne, open the trading day in Paris.
Advicenne specializes in the research and development of drugs for the treatment of neglected neurological and nephrological diseases, mostly among children.